Published in J Neurooncol on July 18, 2012
MRI-based assessment of the pineal gland in a large population of children aged 0-5 years and comparison with pineoblastoma: part II, the cystic gland. Neuroradiology (2016) 0.77
High-resolution MRI using orbit surface coils for the evaluation of metastatic risk factors in 143 children with retinoblastoma: Part 1: MRI vs. histopathology. Neuroradiology (2015) 0.76
MRI-based assessment of the pineal gland in a large population of children aged 0-5 years and comparison with pineoblastoma: part I, the solid gland. Neuroradiology (2016) 0.75
Blood flow velocity in monocular retinoblastoma assessed by color doppler. Clinics (Sao Paulo) (2015) 0.75
Diffusion-weighted imaging to assess treatment response in a child with trilateral retinoblastoma. Pediatr Radiol (2013) 0.75
Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma. J Clin Oncol (1999) 2.28
Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma). Arch Ophthalmol (2001) 2.22
Trilateral retinoblastoma: is the location of the intracranial tumor important? Cancer (1999) 2.14
Chemoreduction for retinoblastoma. Arch Ophthalmol (2003) 1.46
Routine neuroimaging in retinoblastoma for the detection of intracranial tumors. Arch Ophthalmol (2001) 1.46
Second primary tumors in patients with hereditary retinoblastoma: a register-based follow-up study, 1945-1994. Int J Cancer (1996) 1.33
Trilateral retinoblastoma: clinical and radiologic progression. AJR Am J Roentgenol (2004) 1.27
Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma. Pediatr Blood Cancer (2011) 1.26
Trilateral retinoblastoma. Lancet (1980) 1.05
Guidelines for imaging retinoblastoma: imaging principles and MRI standardization. Pediatr Radiol (2011) 1.03
Clinical variations of trilateral retinoblastoma: a report of 13 cases. J Pediatr Ophthalmol Strabismus (1994) 0.98
Approaches to treatment for extraocular retinoblastoma: Children's Hospital Los Angeles experience. J Pediatr Hematol Oncol (2004) 0.98
Benign pineal cysts in children with bilateral retinoblastoma: a new variant of trilateral retinoblastoma? Pediatr Blood Cancer (2006) 0.96
Trilateral retinoblastoma: potentially curable with intensive chemotherapy. Pediatr Blood Cancer (2010) 0.94
Cystic lesions of the pineal region--MRI and pathology. Neuroradiology (2000) 0.92
Successful treatment of early detected trilateral retinoblastoma using standard infant brain tumor therapy. Pediatr Blood Cancer (2010) 0.91
Trilateral retinoblastoma--incidence and outcome: a decade of experience. Int J Radiat Oncol Biol Phys (1994) 0.91
Pineal cysts in childhood. Childs Nerv Syst (2003) 0.90
Brain abnormalities on MR imaging in patients with retinoblastoma. AJNR Am J Neuroradiol (2010) 0.88
Clinical presentation, treatment, and outcome of trilateral retinoblastoma. Cancer (1991) 0.84
Pineal cyst: normal or pathological? Neuroradiology (1993) 0.83
Retinoblastoma: clinical presentation and the role of neuroimaging. AJNR Am J Neuroradiol (2001) 0.83
Pineal cyst simulating pinealoblastoma in 11 children with retinoblastoma. Arch Ophthalmol (2006) 0.82
Trilateral retinoblastoma. Pediatr Blood Cancer (2007) 0.81
Radiologic-pathologic correlation. Bilateral retinoblastoma with coexistent pinealoblastoma (trilateral retinoblastoma). AJNR Am J Neuroradiol (1995) 0.81
Trilateral retinoblastoma: an institutional experience and review of the literature. Childs Nerv Syst (2009) 0.81
Successful treatment of trilateral retinoblastoma with conventional and high-dose chemotherapy plus radiotherapy: a case report. J Pediatr Hematol Oncol (2010) 0.79
Imaging in the trilateral retinoblastoma syndrome. Neuroradiology (1996) 0.78
Screening for pineoblastoma in patients with retinoblastoma. Arch Ophthalmol (2002) 0.78
Concurrent pineoblastoma and unilateral retinoblastoma: a forme fruste of trilateral retinoblastoma? Neurosurgery (1985) 0.77
Association of a suprasellar mass and intraocular retinoblastoma: a variant of pineal trilateral retinoblastoma? Pediatr Neurosurg (1996) 0.77
Trilateral retinoblastoma: bilateral retinoblastoma with pinealoblastoma. Can J Ophthalmol (1984) 0.77
Trilateral retinoblastoma: a case report. J Korean Med Sci (2002) 0.76
Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol (2006) 20.17
The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol (2010) 6.61
The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res (2010) 6.09
When to use agreement versus reliability measures. J Clin Epidemiol (2006) 5.24
The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol (2010) 4.10
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. Lancet Neurol (2009) 3.65
The IC3D classification of the corneal dystrophies. Cornea (2008) 3.46
Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond. Radiographics (2006) 3.37
Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res (2011) 3.27
Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. J Natl Cancer Inst (2008) 3.13
The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol (2008) 2.94
Software-recorded and self-reported duration of computer use in relation to the onset of severe arm-wrist-hand pain and neck-shoulder pain. Occup Environ Med (2010) 2.89
Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change. Health Qual Life Outcomes (2006) 2.88
Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol (2003) 2.74
Multidisciplinary rehabilitation for subacute low back pain: graded activity or workplace intervention or both? A randomized controlled trial. Spine (Phila Pa 1976) (2007) 2.74
Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients. Clin Cancer Res (2006) 2.71
Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab (2007) 2.68
Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol (2002) 2.52
Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology (2005) 2.47
CNGB3 mutations account for 50% of all cases with autosomal recessive achromatopsia. Eur J Hum Genet (2005) 2.37
Sentinel-lymph-node procedure in colon and rectal cancer: a systematic review and meta-analysis. Lancet Oncol (2011) 2.36
Multifactorial intervention to reduce falls in older people at high risk of recurrent falls: a randomized controlled trial. Arch Intern Med (2010) 2.34
Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma. Pediatr Blood Cancer (2009) 2.32
Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. Lancet Oncol (2013) 2.32
Spinal cord ischemia: clinical and imaging patterns, pathogenesis, and outcomes in 27 patients. Arch Neurol (2006) 2.19
Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2. Am J Hum Genet (2004) 2.13
Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol (2005) 2.07
Different aspects of visual impairment as risk factors for falls and fractures in older men and women. J Bone Miner Res (2004) 2.04
TRPM1 is mutated in patients with autosomal-recessive complete congenital stationary night blindness. Am J Hum Genet (2009) 1.93
Evaluation of the methodological quality of systematic reviews of health status measurement instruments. Qual Life Res (2009) 1.82
Randomised controlled trial of integrated care to reduce disability from chronic low back pain in working and private life. BMJ (2010) 1.81
Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study. J Clin Oncol (2010) 1.81
Mutations in CABP4, the gene encoding the Ca2+-binding protein 4, cause autosomal recessive night blindness. Am J Hum Genet (2006) 1.77
A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer (2006) 1.76
Effects of multidisciplinary integrated care on quality of care in residential care facilities for elderly people: a cluster randomized trial. CMAJ (2011) 1.75
Germline BAP1 mutations predispose to renal cell carcinomas. Am J Hum Genet (2013) 1.69
Global Perceived Effect scales provided reliable assessments of health transition in people with musculoskeletal disorders, but ratings are strongly influenced by current status. J Clin Epidemiol (2010) 1.69
Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients. J Nucl Med (2009) 1.68
Improved detection of active multiple sclerosis lesions: 3D subtraction imaging. Radiology (2010) 1.68
Minimally important change determined by a visual method integrating an anchor-based and a distribution-based approach. Qual Life Res (2006) 1.68
Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of Leber congenital amaurosis. PLoS Med (2006) 1.67
Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration. Proc Natl Acad Sci U S A (2002) 1.67
Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma. J Clin Oncol (2011) 1.64
The effect of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis. Semin Arthritis Rheum (2011) 1.63
Psychometric properties of vision-related quality of life questionnaires: a systematic review. Ophthalmic Physiol Opt (2004) 1.62
Implementation of clinical guidelines on physical therapy for patients with low back pain: randomized trial comparing patient outcomes after a standard and active implementation strategy. Phys Ther (2005) 1.62
Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study. Diabetes Care (2002) 1.60
Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease. J Alzheimers Dis (2012) 1.57
Variable selection under multiple imputation using the bootstrap in a prognostic study. BMC Med Res Methodol (2007) 1.57
Mapping the human connectome at multiple scales with diffusion spectrum MRI. J Neurosci Methods (2011) 1.56
Relationship between brain perfusion computed tomography variables and cerebral perfusion pressure in severe head trauma patients. Crit Care Med (2004) 1.55
Differential item functioning of the Functional Independence Measure in higher performing neurological patients. J Rehabil Med (2005) 1.54
Clinical effect of neutralizing antibodies to interferon beta that persist long after cessation of therapy for multiple sclerosis. Arch Neurol (2010) 1.50
The combined effect of lower-limb multilevel botulinum toxin type a and comprehensive rehabilitation on mobility in children with cerebral palsy: a randomized clinical trial. Arch Phys Med Rehabil (2006) 1.50
Inter-rater agreement and reliability of the COSMIN (COnsensus-based Standards for the selection of health status Measurement Instruments) checklist. BMC Med Res Methodol (2010) 1.50
A workplace intervention for sick-listed employees with distress: results of a randomised controlled trial. Occup Environ Med (2010) 1.49
24-item Roland-Morris Disability Questionnaire was preferred out of six functional status questionnaires for post-lumbar disc surgery. J Clin Epidemiol (2004) 1.48
Bmi1 loss produces an increase in astroglial cells and a decrease in neural stem cell population and proliferation. J Neurosci (2005) 1.48
Double concentric autofluorescence ring in NR2E3-p.G56R-linked autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci (2012) 1.47
Chemoreduction for retinoblastoma. Arch Ophthalmol (2003) 1.46
Avoidance of activities in early symptomatic knee osteoarthritis: results from the CHECK cohort. Ann Behav Med (2012) 1.46
Clinicians are right not to like Cohen's κ. BMJ (2013) 1.44
Retinoblastoma. Orphanet J Rare Dis (2006) 1.44
Establishment and characterization of a panel of human uveal melanoma xenografts derived from primary and/or metastatic tumors. Clin Cancer Res (2010) 1.42
Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla. Eur Radiol (2010) 1.41
Real-world evidence of suboptimal blood pressure control in patients with type 2 diabetes. J Hypertens (2015) 1.40
IC3D classification of corneal dystrophies--edition 2. Cornea (2015) 1.39
Missing evidences in cancer genetics: the retinoblastoma paradigm. Cell Oncol (2008) 1.39
Novel mutations in FRMD7 in X-linked congenital nystagmus. Mutation in brief #963. Online. Hum Mutat (2007) 1.38
Chemotherapy for retinoblastoma. Ophthalmol Clin North Am (2005) 1.38
Mutations in PIP5K3 are associated with François-Neetens mouchetée fleck corneal dystrophy. Am J Hum Genet (2005) 1.35
Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor? Ophthalmology (2007) 1.33
Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of epithelial growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1). Implications for macular degenerations. J Biol Chem (2004) 1.32
The spinal cord in multiple sclerosis: relationship of high-spatial-resolution quantitative MR imaging findings to histopathologic results. Radiology (2004) 1.32
The benefits outweigh the risks for patients undergoing chiropractic care for neck pain: a prospective, multicenter, cohort study. J Manipulative Physiol Ther (2007) 1.32
Bietti's crystalline corneoretinal dystrophy: a cross-sectional study. Retina (2004) 1.31
Mutations in CNNM4 cause recessive cone-rod dystrophy with amelogenesis imperfecta. Am J Hum Genet (2009) 1.28
BBS genotype-phenotype assessment of a multiethnic patient cohort calls for a revision of the disease definition. Hum Mutat (2011) 1.28
Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI. Neurology (2013) 1.27
The transcription factor c-Maf controls touch receptor development and function. Science (2012) 1.27
Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis. Arch Neurol (2009) 1.26
Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration. J Magn Reson Imaging (2006) 1.26
Brain atrophy and lesion load predict long term disability in multiple sclerosis. J Neurol Neurosurg Psychiatry (2013) 1.26
Whole-exome sequencing identifies mutations in GPR179 leading to autosomal-recessive complete congenital stationary night blindness. Am J Hum Genet (2012) 1.25
Cost-effectiveness of a workplace intervention for sick-listed employees with common mental disorders: design of a randomized controlled trial. BMC Public Health (2008) 1.25
Three ways to quantify uncertainty in individually applied "minimally important change" values. J Clin Epidemiol (2009) 1.25
Genotype-phenotype correlations in hereditary familial retinoblastoma. Hum Mutat (2007) 1.25
Bilateral disease and new trends in Wilms tumour. Pediatr Radiol (2007) 1.24
Ophthalmologic and intraocular non-Hodgkin's lymphoma: a large single centre study of initial characteristics, natural history, and prognostic factors. Hematol Oncol (2004) 1.23
The effectiveness of high-intensity versus low-intensity back schools in an occupational setting: a pragmatic randomized controlled trial. Spine (Phila Pa 1976) (2006) 1.23
Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter. Radiology (2006) 1.23
Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors. Neuro Oncol (2010) 1.22
Prognostic factors for low back pain in patients referred for physiotherapy: comparing outcomes and varying modeling techniques. Spine (Phila Pa 1976) (2005) 1.22
Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors and liver metastases. Invest Ophthalmol Vis Sci (2009) 1.22